From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Stryker’s US spinal implants sale to VB Spine creates growth opportunities for competitors like Medtronic and Globus in the ...

These data indicate that surgery improves the condition of patients with moderate or intense globus pattern symptoms, but may make symptoms appear in asymptomatic of weakly symptomatic patients.

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...